In clinical trials with sequential patient entry, fixed sample size designs are unjustified on ethical grounds and sequential designs are often impracticable. One solution is a group sequential design ...
This is a preview. Log in through your library . Abstract Context: During the 2009 H1N1 pandemic, computational agent-based models (ABMs) were extensively used to evaluate interventions to control the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback